These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1171 related articles for article (PubMed ID: 18191511)
21. In vitro and in vivo studies of different liposomes containing topotecan. Hao YL; Deng YJ; Chen Y; Wang XM; Zhong HJ; Suo XB Arch Pharm Res; 2005 May; 28(5):626-35. PubMed ID: 15974453 [TBL] [Abstract][Full Text] [Related]
22. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models. Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116 [TBL] [Abstract][Full Text] [Related]
23. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. Wang X; Ishida T; Kiwada H J Control Release; 2007 Jun; 119(2):236-44. PubMed ID: 17399838 [TBL] [Abstract][Full Text] [Related]
24. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection. Ishida T; Atobe K; Wang X; Kiwada H J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355 [TBL] [Abstract][Full Text] [Related]
25. Accumulation of vinblastine into transfersomes and liposomes in response to a transmembrane ammonium sulfate gradient and their cytotoxic/cytostatic activity in vitro. Maswadeh H; Demetzos C; Dimas K; Hatziantoniou S; Georgopoulos A; Rallis M; Dallas P; Papaioannou G Anticancer Res; 2001; 21(4A):2577-83. PubMed ID: 11724324 [TBL] [Abstract][Full Text] [Related]
26. Optimization of vincristine-topotecan combination--paving the way for improved chemotherapy regimens by nanoliposomes. Zucker D; Barenholz Y J Control Release; 2010 Sep; 146(3):326-33. PubMed ID: 20685223 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic and cytotoxic studies of pegylated liposomal daunorubicin. Song H; Zhang J; Han Z; Zhang X; Li Z; Zhang L; Fu M; Lin C; Ma J Cancer Chemother Pharmacol; 2006 May; 57(5):591-8. PubMed ID: 16133530 [TBL] [Abstract][Full Text] [Related]
28. Repeated injections of PEGylated liposomal topotecan induces accelerated blood clearance phenomenon in rats. Ma Y; Yang Q; Wang L; Zhou X; Zhao Y; Deng Y Eur J Pharm Sci; 2012 Apr; 45(5):539-45. PubMed ID: 22155543 [TBL] [Abstract][Full Text] [Related]
29. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats. Kim CK; Han JH J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318 [TBL] [Abstract][Full Text] [Related]
30. Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats. Takahama H; Minamino T; Asanuma H; Fujita M; Asai T; Wakeno M; Sasaki H; Kikuchi H; Hashimoto K; Oku N; Asakura M; Kim J; Takashima S; Komamura K; Sugimachi M; Mochizuki N; Kitakaze M J Am Coll Cardiol; 2009 Feb; 53(8):709-17. PubMed ID: 19232905 [TBL] [Abstract][Full Text] [Related]
31. An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes. Abraham SA; Edwards K; Karlsson G; Hudon N; Mayer LD; Bally MB J Control Release; 2004 May; 96(3):449-61. PubMed ID: 15120901 [TBL] [Abstract][Full Text] [Related]
32. Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts. Zamboni WC; Strychor S; Joseph E; Walsh DR; Zamboni BA; Parise RA; Tonda ME; Yu NY; Engbers C; Eiseman JL Clin Cancer Res; 2007 Dec; 13(23):7217-23. PubMed ID: 18056203 [TBL] [Abstract][Full Text] [Related]
33. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy. Yoshizawa Y; Kono Y; Ogawara K; Kimura T; Higaki K Int J Pharm; 2011 Jun; 412(1-2):132-41. PubMed ID: 21507344 [TBL] [Abstract][Full Text] [Related]
34. Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol. Wang XH; Cai LL; Zhang XY; Deng LY; Zheng H; Deng CY; Wen JL; Zhao X; Wei YQ; Chen LJ Int J Pharm; 2011 May; 410(1-2):169-74. PubMed ID: 21397675 [TBL] [Abstract][Full Text] [Related]
35. Lipophilic cisplatin analogues entrapped in liposomes: role of intraliposomal drug activation in biological activity. Perez-Soler R; Khokhar AR Cancer Res; 1992 Nov; 52(22):6341-7. PubMed ID: 1423280 [TBL] [Abstract][Full Text] [Related]
36. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals. Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115 [TBL] [Abstract][Full Text] [Related]
37. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model. Abu Lila AS; Kizuki S; Doi Y; Suzuki T; Ishida T; Kiwada H J Control Release; 2009 Jul; 137(1):8-14. PubMed ID: 19285528 [TBL] [Abstract][Full Text] [Related]